Stryker Corp.

SYK-N

NYSE:SYK

207.03
8.95 (4.52%)
Stryker Corporation is a Fortune 500 medical technologies firm based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and ...
More at Wikipedia

Analysis and Opinions about SYK-N

Signal
Opinion
Expert
TOP PICK
TOP PICK
February 25, 2016

Healthcare is the only sector that has both top line and earnings growth. Hospital beds, hip and knee replacements. They are geared to the aging demographic.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 25, 2016

Healthcare is the only sector that has both top line and earnings growth. Hospital beds, hip and knee replacements. They are geared to the aging demographic.

COMMENT
COMMENT
January 13, 2016

This is down from its highs and is a good story.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 13, 2016

This is down from its highs and is a good story.

PAST TOP PICK
PAST TOP PICK
November 30, 2015

(A Top Pick Jan 28/14. Up 5.15%.) Loves the company. Very innovative. They are introducing more technology in the operating room. Not only providing the product that goes into your body, but also building the robot that assists the doctor that performed the surgery. Has a great 5 year track record of increasing its dividend. Good strong balance sheet. Strong international sales. Still a Buy.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 30, 2015

(A Top Pick Jan 28/14. Up 5.15%.) Loves the company. Very innovative. They are introducing more technology in the operating room. Not only providing the product that goes into your body, but also building the robot that assists the doctor that performed the surgery. Has a great 5 year track record of increasing its dividend. Good strong balance sheet. Strong international sales. Still a Buy.

PAST TOP PICK
PAST TOP PICK
November 2, 2015

(A Top Pick April 7/14. Up 21.7%.) The healthcare sector is kind of fragmented into biotech, pharmaceutical and equipment. His view on the equipment side is quite constructive. Demographics are positive. Also, you don’t have the regulatory side that you have with the drugs.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 2, 2015

(A Top Pick April 7/14. Up 21.7%.) The healthcare sector is kind of fragmented into biotech, pharmaceutical and equipment. His view on the equipment side is quite constructive. Demographics are positive. Also, you don’t have the regulatory side that you have with the drugs.

PAST TOP PICK
PAST TOP PICK
April 1, 2015

(A Top Pick April 7/14. Up 13.91%.) Part of this company is focused on technology. They are known as the knees and hips type of company. Going forward, this offers a ton of opportunities, anywhere from demographics to healthcare. Good balance sheet and good management team.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 1, 2015

(A Top Pick April 7/14. Up 13.91%.) Part of this company is focused on technology. They are known as the knees and hips type of company. Going forward, this offers a ton of opportunities, anywhere from demographics to healthcare. Good balance sheet and good management team.

TOP PICK
TOP PICK
January 28, 2015

Joint replacements. A great international growth story. The rising middle class globally will be spending more money on health care, so it is a good longer-term global story. Strong balance sheet. Very high return on equity at around 18%-19% consistently. Growing their dividend at around 25% compounded over the last 3-4 years.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 28, 2015

Joint replacements. A great international growth story. The rising middle class globally will be spending more money on health care, so it is a good longer-term global story. Strong balance sheet. Very high return on equity at around 18%-19% consistently. Growing their dividend at around 25% compounded over the last 3-4 years.

PAST TOP PICK
PAST TOP PICK
January 19, 2015

(A Top Pick Nov 19/13. Up 27.13%.) Have recently made acquisitions on the technology side. Longer-term, this company is in great shape.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 19, 2015

(A Top Pick Nov 19/13. Up 27.13%.) Have recently made acquisitions on the technology side. Longer-term, this company is in great shape.

PAST TOP PICK
PAST TOP PICK
November 19, 2014

(A Top Pick Dec 5/13. Up 24.4%.) Fantastic history of increasing the dividend. Well-run company. Good international growth profile. Strong balance sheet. Trading at a very reasonable valuation. A good, long-term growth stock.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 19, 2014

(A Top Pick Dec 5/13. Up 24.4%.) Fantastic history of increasing the dividend. Well-run company. Good international growth profile. Strong balance sheet. Trading at a very reasonable valuation. A good, long-term growth stock.

PAST TOP PICK
PAST TOP PICK
November 14, 2014

(A Top Pick Nov 19/13. Up 20.73%.) Artificial hips, joints etc. There has been some consolidation and there will be more. This is one of the bigger names, so they could be the buyer. Technology is playing a big role. Demographics will play a big role in this. He is also looking at other names in this space.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 14, 2014

(A Top Pick Nov 19/13. Up 20.73%.) Artificial hips, joints etc. There has been some consolidation and there will be more. This is one of the bigger names, so they could be the buyer. Technology is playing a big role. Demographics will play a big role in this. He is also looking at other names in this space.

COMMENT
COMMENT
November 11, 2014

Medical devices, such as hips and knees. She does like the space which plays into aging demographics. She gets her exposure through Johnson & Johnson (JNJ-N), which has other divisions making their earnings more stable.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 11, 2014

Medical devices, such as hips and knees. She does like the space which plays into aging demographics. She gets her exposure through Johnson & Johnson (JNJ-N), which has other divisions making their earnings more stable.

WEAK BUY
WEAK BUY
October 29, 2014

Generally, this is fine. It is a good company. They do medical beds, surgical implants and things like that. Has struggled at various points, but overall he feels there is a bit of a renaissance in healthcare and hospitalizations. Probably a mild Buy, not a table pounder.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
October 29, 2014

Generally, this is fine. It is a good company. They do medical beds, surgical implants and things like that. Has struggled at various points, but overall he feels there is a bit of a renaissance in healthcare and hospitalizations. Probably a mild Buy, not a table pounder.

PAST TOP PICK
PAST TOP PICK
October 6, 2014

(A Top Pick Nov 19/13. Up 14.69%.) This company makes knees, hips and are starting to get into some of the shoulder area. Likes the name. Demographics will play favourably. Over the long-term, he is constructive on this company.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
October 6, 2014

(A Top Pick Nov 19/13. Up 14.69%.) This company makes knees, hips and are starting to get into some of the shoulder area. Likes the name. Demographics will play favourably. Over the long-term, he is constructive on this company.

PAST TOP PICK
PAST TOP PICK
September 16, 2014

(A Top Pick Oct 8/13. Up 25.76%.) Great, great growth story. Compounded dividend growth in the last 5 years was around 25% per annum and he expects more of this. Great growth story in terms of healthcare story in the US with more people spending money on surgery.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
September 16, 2014

(A Top Pick Oct 8/13. Up 25.76%.) Great, great growth story. Compounded dividend growth in the last 5 years was around 25% per annum and he expects more of this. Great growth story in terms of healthcare story in the US with more people spending money on surgery.

COMMENT
COMMENT
August 29, 2014

In valuations, they are at the lower end of the group. There are a few factors going on, more industry-specific. You would think there was a very good demand from an aging population, but you are also getting all the change within the industry, where there are larger buying groups. With the valuations where they are, this is okay, but you’re not getting a fabulous deal. Pretty good company and a pretty good stock to own. Trading at 17X forward earnings.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
August 29, 2014

In valuations, they are at the lower end of the group. There are a few factors going on, more industry-specific. You would think there was a very good demand from an aging population, but you are also getting all the change within the industry, where there are larger buying groups. With the valuations where they are, this is okay, but you’re not getting a fabulous deal. Pretty good company and a pretty good stock to own. Trading at 17X forward earnings.

TOP PICK
TOP PICK
April 7, 2014

Sector that has come up a little in value. Great long term demographic. Knees and Hips, expanding into Shoulders and Feet. 4-6% organic growth plus any acquisitions. Yield is marginal, 1.5%, but returning something.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 7, 2014

Sector that has come up a little in value. Great long term demographic. Knees and Hips, expanding into Shoulders and Feet. 4-6% organic growth plus any acquisitions. Yield is marginal, 1.5%, but returning something.

Showing 61 to 75 of 89 entries